Roni Mamluk Ayala Pharmaceuticals, Inc. (AYLA) insider trading activity

Roni Mamluk is President & CEO of Ayala Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of AYLA, which is worth approximately $0. The most recent transaction as insider was on Jan 19, 2023, when has been sold 265,345 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Roni Mamluk Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 19 2023	SELL Sale (or disposition) back to the issuer	-	265,345 Reduced 100.0%	0 Common Stock
May 16 2022	BUY Grant, award, or other acquisition	-	120,000 Added 31.14%	265,345 Common Stock
Feb 24 2021	SELL Open market or private sale	$187,920 $17.4 p/Share	10,800 Reduced 6.92%	145,345 Common Stock
Feb 23 2021	SELL Open market or private sale	$127,484 $17.89 p/Share	7,126 Reduced 4.36%	156,145 Common Stock
Feb 22 2021	SELL Open market or private sale	$301,872 $19.86 p/Share	15,200 Reduced 8.52%	163,271 Common Stock
Jan 21 2021	SELL Open market or private sale	$21,146 $15.04 p/Share	1,406 Reduced 0.78%	178,471 Common Stock
Jan 20 2021	SELL Open market or private sale	$292,574 $15.03 p/Share	19,466 Reduced 9.77%	179,877 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	34,080 Added 14.6%	199,343 Common Stock

Roni Mamluk

President & CEO

Rehovot, L3

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AYLA shares.

Notify only if

Value

Insider Trading

Get notified when an Ayala Pharmaceuticals, Inc. insider buys or sells AYLA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Ayala Pharmaceuticals, Inc.

Track Activities on AYLA

Account